Standout Papers

Genetic drug target validation using Mendelian randomisation 2020 2026 2022 2024245
  1. Genetic drug target validation using Mendelian randomisation (2020)
    Amand F. Schmidt, Chris Finan et al. Nature Communications

Immediate Impact

2 from Science/Nature 70 standout
Sub-graph 1 of 21

Citing Papers

MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation
2024 Standout
Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial
2024 Standout
3 intermediate papers

Works of Benoît Tyl being referenced

A population‐based study of 92 clinically recognized risk factors for heart failure: co‐occurrence, prognosis and preventive potential
2021
Comparison of Outcome Adjudication by Investigators and by a Central End Point Committee in Heart Failure Trials
2020
and 1 more

Author Peers

Author Last Decade Papers Cites
Benoît Tyl 249 58 175 141 27 746
Ghada N. Farhat 163 60 119 63 26 973
José Juan Alemán Sánchez 241 90 139 57 30 787
Hayan Jouni 277 91 191 256 47 911
Sarah L. Hulin-Curtis 83 77 167 137 22 902
Shahnaz Khan 176 102 60 94 29 760
Venexia Walker 108 79 121 212 34 664
Akl C. Fahed 168 99 166 336 43 840
Diane T. Smelser 135 55 190 316 36 785
Ajay Yesupriya 66 74 129 191 28 688
Helen R. Warren 266 41 219 248 40 761

All Works

Loading papers...

Rankless by CCL
2026